Zhao Da Jun, born in 1970. He obtained a Master's degree in biology from Fudan University in July 1995 and a Master's degree in business administration from the University of Hong Kong in November 2001. He served as an assistant professor at the Law School of Fudan University from August 1995 to October 1996. He was a cofounder of the Company and worked at the Company since November 1996. Since January 2002, he has been appointed as an Executive Director and the deputy general manager of the Company. At the same time, he is concurrently appointed as the chairman of the Board of directors of Shanghai Tracing Bio-technology Co., Ltd.

Xue Yan, born in 1981. She graduated from Shanghai University of Finance & Economics with a bachelor’s degree of International Accounting in July 2004 and obtained an MBA from the University of Hong Kong in November 2018. She is a member of the Hong Kong Institute of Certified Public Accountants (HKICPA), a fellow of the Association of Chartered Certified Accountants (ACCA), and a member of the Chinese Institute of Certified Public Accountants (CICPA). She is qualified as an international certified internal auditor. She served in the Assurance Department of PricewaterhouseCoopers Zhong Tian LLP from August 2004 to May 2010. Since 2010, she has been the Chief Financial Officer and an authorized representative of the Company. She is also the director of Fernovelty and supervisor of Shanghai Handu.

Li Jun, born in 1968. He graduated from Fudan University with a master’s degree of Biology in July 1993. He has been responsible for several research projects of the Natural Science Fund, and has published numerous articles. He is a certified pharmacist. He was a teaching assistant and lecturer at Fudan University from August 1993 to November 1996, during which he also served as deputy chief technology officer of Zhejiang Shenghua Biok Biology Co. Ltd. and was involved in the research and manufacture of three new drugs. He was a cofounder of the Company and worked at the Company since November 1996. Since January 2002, he has been appointed as the deputy general manager of the Company.

Qin Lei, born in 1974. He obtained a bachelor's degree in basic Chinese medicine from Shanghai University of Traditional Chinese Medicine in June 1997. He used to be a resident in LongHua Hospital Shanghai University of Traditional Chinese Medicine and an assistant researcher in Shanghai University of Traditional Chinese Medicine from July 1997 to August 2001. He worked in marketing and product sales for Hong Kong Life Sciences and Technologies Group Limited, Shanghai Lei Yun Shang Pharmaceutical Co. and Zhejiang Kang Lai Te Pharmaceutical Co., Ltd from September 2001 to May 2006. He has worked as the product manager, the marketing manager and the marketing director of the Company since June 2006. He is a deputy general manager of Marketing Center of the Company.

Yu Dai Qing, born in 1973. She graduated from Shandong University with a bachelor's degree of Chemistry in July 1995 and a master's degree of Analytical Chemistry in July 1998. She successively engaged in quality research and analysis of new drug development, quality control of pharmaceutical manufacturing, establishment of quality management system and daily operation management relating to pharmaceutical manufacturing from 2001. She was appointed as an employee representative Supervisor and being the quality director of the Company from November 2016.

Chen Yu, born in 1974. He obtained a bachelor's degree in English pharmacy from Shenyang Pharmaceutical University in June 1998 and a Master's degree in Pharmaceutical Engineering from Tianjin University in February 2008. He has extensive experience in pharmaceutical production management, quality assurance and GMP certification matters. He has worked as an production supervisor, compliance specialist, compliance supervisor and compliance manager of Xian-Janssen Pharmaceutical Ltd. from April 1999 to July 2011. He has worked as a quality director of Zhejiang Jiuzhou Pharmaceutical Co from July 2011 to April 2014. Since April 2014, he has been the deputy general manager of Taizhou Fudan-Zhangjiang Pharmaceutical Co., Ltd (the subsidiary of the Company).